CRISPR THERAPEUTICS AG (CRSP) /
The profitability of CRISPR THERAPEUTICS AG over the past 10 years
Chart CRISPR THERAPEUTICS AG: operating income, net income, fiscal 2016–2025 Open the chart →CRISPR THERAPEUTICS AG reported a net loss of $581.6M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $664.57M. It reported a profit in 2 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2020, 2022, 2023, 2024 and 2025. Its highest net income in these years was $377.66M, in fiscal 2021.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$664.57M | -$581.6M |
| 2024ended Dec 31, 2024 | -$466.57M | -$366.25M |
| 2023ended Dec 31, 2023 | -$222.54M | -$153.61M |
| 2022ended Dec 31, 2022 | -$673.16M | -$650.17M |
| 2021ended Dec 31, 2021 | $373.53M | $377.66M |
| 2020ended Dec 31, 2020 | -$354.44M | -$348.87M |
| 2019ended Dec 31, 2019 | $46.74M | $66.86M |
| 2018ended Dec 31, 2018 | -$158.94M | -$164.98M |
| 2017ended Dec 31, 2017 | -$64.65M | -$68.36M |
| 2016ended Dec 31, 2016 | -$68.13M | -$23.18M |
Fiscal years as CRISPR THERAPEUTICS AG reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on CRISPR THERAPEUTICS AG
- The revenue of CRISPR THERAPEUTICS AG
- The cash flow of CRISPR THERAPEUTICS AG
- The debt of CRISPR THERAPEUTICS AG
- All of CRISPR THERAPEUTICS AG's financials, charted
Companies of a similar size
- CUZCOUSINS PROPERTIES INC
- CIGIColliers International Group Inc.
- RYNRAYONIER INC.
- MATMATTEL INC /DE/
- NWENORTHWESTERN ENERGY GROUP, INC.
Not investment advice. This page shows what CRISPR THERAPEUTICS AG filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.